SYNOPSIS
for the euglobulin lysis time test from plasma with added EACA demonstrated that some 85 % of the EACA was present in the supernatant, normally discarded during the test. Similarly, cellulose-acetate electrophoresis of the supernatant and euglobulin fractions from plasma containing Trasylol demonstrated the drug in the supernatant only. These findings indicate that when acetic acid is added to plasma containing EACA or Trasylol only a small proportion of the drug is precipitated with the euglobulin fraction. The euglobulin lysis time is thus an inaccurate index of the neutralization of hyperfibrinolysis by antifibrinolytic drugs.
Hyperfibrinolysis has been associated with a variety of disease entities, occurring either secondary to disseminated intravascular coagulation (MacKay, 1965) or more rarely as a primary pathological entity (Merskey, Johnson, Kleiner, and Wohl, 1967 (Fearnley, 1960) , plasminogen (Remmert and Cohen, 1949) , and fibrinogen (Ellis and Stransky, 1961) assays were performed according to standard methods. Fibrin plates for determining fibrinolytic activity were prepared according to the method of Astrup and Mullertz (1952) (Fig. 1) . Fibrin plate studies showed no fibrinolysis when whole plasma was plated, but markedly excessive fibrinolysis when the euglobulin fraction only was plated (Fig. 2) . In the same way, the dilute clot, but not the euglobulin, lysis times, reflected clinical control of fibrinolysis by Trasylol in the anhepatic baboon (Fig. 3) .
EUGLOBULIN LYSIS TIME AND INDUCED

INCREASED FIBRINOLYSIS in vitro
Streptokinase' added to normal plasma in a concentration of 50 units per ml results in activation of fibrinolysis with marked shortening of the dilute clot and euglobulin lysis times. On the subsequent addition of increasing concentrations of EACA2 (1-60 mg per ml) to aliquots ofthe streptokinase-activated plasma the dilute clot lysis time reverted to normal. However, the euglobulin lysis time of the activated plasma remained abnormally short in spite of the addition of EACA (Table) .
'Lederle Laboratories, USA 'Kabi, Sweden. To aliquots of normal plasma, and normal plasma in which the fibrinolytic activity was activated by the addition of streptokinase (25 units per ml), EACA (5 mg per ml) or Trasyloll (75,000 units per ml) was added. Aliquots of these plasmas (0-5 ml) were then diluted with 9-5 ml distilled water and the euglobulin fractions precipitated with 1 % acetic acid. The precipitates and supernatants from the EACA and Trasylol-containing plasmas were submitted to paper chromatography and cellulose acetate electrophoresis respectively. The results indicated that the EACA and Trasylol were present almost exclusively in the supernatants (Figs. 4 and 5) . Control samples included euglobulin precipitates and supernatants prepared from normal plasma with and without added streptokinase (25 units per ml). The EACA and appropriate blanks on the chromatograms were eluted with 0-01 NHCI. An eluate from the EACA standard was scanned spectrophotometrically and its maximum absorption was at 250 m,u. The EACA eluted from the chromatograms of the euglobulin precipitates and supernatants were quantitated by the optical density at 250 m,u. The results indicated that 15% of the EACA was in the precipitate and 85% in the supernatant.
Discussion
The rationale for precipitating the euglobulin of plasma before measuring fibrinolytic activity is the separation of the precipitable fibrinolytic enzymes from the non-precipitable inhibitors, antiplasmin and anti-activator. Euglobulin contains the plasminogen activator and plasminogen of plasma, 25 % of the fibrinogen, but only traces of the antiplasmins (Kowalski, Kopec, and Niewiarowski, 1959) . The sensitivity of this test system becomes greater than that of the dilute clot lysis time in which the fibrinolytic inhibitors are not removed. This is reflected by shortening of the clot lysis time of normal plasma from 12 to 24 hours in the dilute clot lysis time to five to 10 hours in the euglobulin lysis time.
'Bayer, Germany. Sherry, Fletcher, Alkjaersig, and Sawyer (1959) have shown that administered EACA is unlikely to be protein bound, for the drug is readily dialyzable from plasma. By ultrafiltration techniques and protein-free filtrate assays, McNicol, Fletcher, Alkjaersig, and Sherry (1962) found recovery of the drug from the plasma to be quantitative. The present studies in addition have shown that the binding of fibrinolytic enzymes by EACA and Trasylol is disrupted by euglobulin precipitation. If the euglobulin lysis time is used to monitor antifibrinolytic therapy the antifibrinolytic drugs are precipitated in minimal amounts in the euglobulin fraction, and the neutralization of excessive fibrinolysis is thus not reflected.
